Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Data shows Novartis’ psoriasis drug is more effective than rival

Novartis is developing Cosentyx as a fully-human biologic to inhibit IL-17A. Credit: Andrew from Flickr.



  • Data shows Novartis’ psoriasis drug Cosentyx better than rival drug
Close
Close
Close

Go Top